{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T22:28:31Z","timestamp":1778797711092,"version":"3.51.4"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Protein Expression and Purification"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.pep.2026.106925","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T17:09:40Z","timestamp":1775754580000},"page":"106925","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Screening and characterization of EGFR-targeted specific nanobodies"],"prefix":"10.1016","volume":"241","author":[{"given":"Jing","family":"Geng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long","family":"Sha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuaiying","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianfeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.pep.2026.106925_bib1","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1038\/nm.3388","article-title":"The quest to overcome resistance to EGFR-targeted therapies in cancer","volume":"19","author":"Chong","year":"2013","journal-title":"Nat Med"},{"issue":"10","key":"10.1016\/j.pep.2026.106925_bib2","doi-asserted-by":"crossref","DOI":"10.1002\/pro.5141","article-title":"Analysis of EGFR binding hotspots for design of new EGFR inhibitory biologics","volume":"33","author":"Tydings","year":"2024","journal-title":"Protein Sci."},{"issue":"30","key":"10.1016\/j.pep.2026.106925_bib3","doi-asserted-by":"crossref","first-page":"50209","DOI":"10.18632\/oncotarget.16854","article-title":"Epidermal growth factor receptor (EGFR): a rising star in the era of precision medicine of lung cancer","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.pep.2026.106925_bib4","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12943-018-0793-1","article-title":"EGFR-TKIs resistance via EGFR-independent signaling pathways","volume":"17","author":"Liu","year":"2018","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.pep.2026.106925_bib5","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.jtho.2016.12.014","article-title":"Driven by mutations: the predictive value of mutation subtype in EGFR-mutated non-small cell lung cancer","volume":"12","author":"Castellanos","year":"2017","journal-title":"J. Thorac. Oncol."},{"issue":"1","key":"10.1016\/j.pep.2026.106925_bib6","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1038\/s41467-023-38115-2","article-title":"TMEM25 inhibits monomeric EGFR-mediated STAT3 activation in basal state to suppress triple-negative breast cancer progression","volume":"14","author":"Bi","year":"2023","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.pep.2026.106925_bib7","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1093\/neuonc\/nox191","article-title":"EGFR heterogeneity and implications for therapeutic intervention in glioblastoma","volume":"20","author":"Eskilsson","year":"2018","journal-title":"Neuro Oncol."},{"issue":"12","key":"10.1016\/j.pep.2026.106925_bib8","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1038\/s41388-017-0045-7","article-title":"Epidermal growth factor receptor and EGFRvIII in glioblastoma: signaling pathways and targeted therapies","volume":"37","author":"An","year":"2018","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.pep.2026.106925_bib9","article-title":"Gefitinib for advanced non-small cell lung cancer","volume":"1","author":"Sim","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"10.1016\/j.pep.2026.106925_bib10","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.1038\/s41598-017-04258-8","article-title":"Blocking autophagy improves the anti-tumor activity of afatinib in lung adenocarcinoma with activating EGFR mutations in vitro and in vivo","volume":"7","author":"Hu","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.pep.2026.106925_bib11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJMoa1913662","article-title":"Overall survival with osimertinib in untreated, EGFR-mutated advanced NSCLC","volume":"382","author":"Ramalingam","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.pep.2026.106925_bib12","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1080\/14712598.2018.1452906","article-title":"Cetuximab for treating non-small cell lung cancer","volume":"18","author":"Mazzarella","year":"2018","journal-title":"Expet Opin. Biol. Ther."},{"issue":"1","key":"10.1016\/j.pep.2026.106925_bib13","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/imr.13385","article-title":"Nanobody-based heavy chain antibodies and chimeric antibodies","volume":"328","author":"Koch-Nolte","year":"2024","journal-title":"Immunol. Rev."},{"issue":"6428","key":"10.1016\/j.pep.2026.106925_bib14","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/363446a0","article-title":"Naturally occurring antibodies devoid of light chains","volume":"363","author":"Hamers-Casterman","year":"1993","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.pep.2026.106925_bib15","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0161-5890(00)00081-X","article-title":"Llama heavy-chain V regions consist of at least four distinct subfamilies revealing novel sequence features","volume":"37","author":"Harmsen","year":"2000","journal-title":"Mol. Immunol."},{"issue":"9","key":"10.1016\/j.pep.2026.106925_bib16","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1007\/s00216-019-01633-4","article-title":"Nanobody: outstanding features for diagnostic and therapeutic applications","volume":"411","author":"Salvador","year":"2019","journal-title":"Anal. Bioanal. Chem."},{"issue":"7","key":"10.1016\/j.pep.2026.106925_bib17","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.str.2013.05.008","article-title":"Structural evaluation of EGFR inhibition mechanisms for nanobodies\/VHH domains","volume":"21","author":"Schmitz","year":"2013","journal-title":"Structure"},{"issue":"12","key":"10.1016\/j.pep.2026.106925_bib18","doi-asserted-by":"crossref","first-page":"6737","DOI":"10.1007\/s11033-013-2790-1","article-title":"Efficient growth inhibition of EGFR over-expressing tumor cells by an anti-EGFR nanobody","volume":"40","author":"Omidfar","year":"2013","journal-title":"Mol. Biol. Rep."},{"issue":"5","key":"10.1016\/j.pep.2026.106925_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmr.2025.100076","article-title":"Cracking the EGFR code: cancer biology, resistance mechanisms, and future therapeutic frontiers","volume":"77","author":"Du","year":"2025","journal-title":"Pharmacol. Rev."},{"issue":"8","key":"10.1016\/j.pep.2026.106925_bib20","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1002\/ijc.26145","article-title":"A biparatopic anti-EGFR nanobody efficiently inhibits solid tumour growth","volume":"129","author":"Roovers","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.pep.2026.106925_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.pep.2025.106680","article-title":"Preparation and characterization of LGR5 LOOP region-specific nanobodies","volume":"229","author":"Jia","year":"2025","journal-title":"Protein Expr. Purif."},{"issue":"11","key":"10.1016\/j.pep.2026.106925_bib22","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1038\/s41401-020-00574-4","article-title":"Development of a nanobody-based immunoassay for the sensitive detection of fibrinogen-like protein 1","volume":"42","author":"Zhang","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.pep.2026.106925_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.pep.2023.106267","article-title":"Preparation and characterization of nanobodies targeting SARS-CoV-2 papain-like protease","volume":"207","author":"Qiao","year":"2023","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.pep.2026.106925_bib24","doi-asserted-by":"crossref","first-page":"7173","DOI":"10.2147\/IJN.S431619","article-title":"Screening, expression and identification of nanobody against Monkeypox virus A35R","volume":"18","author":"Meng","year":"2023","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.pep.2026.106925_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.pep.2023.106268","article-title":"A procedure for producing an anti-AXL nanobody in E. coli","volume":"207","author":"Lan","year":"2023","journal-title":"Protein Expr. Purif."},{"issue":"6","key":"10.1016\/j.pep.2026.106925_bib26","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1007\/s12250-021-00436-1","article-title":"Generation and characterization of a nanobody against SARS-CoV","volume":"36","author":"Li","year":"2021","journal-title":"Virol. Sin."}],"container-title":["Protein Expression and Purification"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1046592826000483?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1046592826000483?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T21:52:29Z","timestamp":1778795549000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1046592826000483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":26,"alternative-id":["S1046592826000483"],"URL":"https:\/\/doi.org\/10.1016\/j.pep.2026.106925","relation":{},"ISSN":["1046-5928"],"issn-type":[{"value":"1046-5928","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Screening and characterization of EGFR-targeted specific nanobodies","name":"articletitle","label":"Article Title"},{"value":"Protein Expression and Purification","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pep.2026.106925","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106925"}}